Response to ACMD: cannabis-derived medicinal products, 21 September 2018

Home Secretary responds to the recommendations of the Advisory Council on the Misuse of Drugs about scheduling of cannabis-derived medicinal products.


Government response to the further ACMD recommendations of 11 September

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


Letter from the Home Secretary and the Secretary of State for Health and Social Care, to the chair of the ACMD, in response to the further ACMD advice to the government of 11 September on scheduling cannabis-derived medicinal products.

Published 21 September 2018